Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 8648367

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1996 Apr
First author
Rothenberg ML

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Rothenberg ML
      type
      Author
    2. name
      Eckardt JR
      type
      Author
    3. name
      Kuhn JG
      type
      Author
    4. name
      Burris HA 3rd
      type
      Author
    5. name
      Nelson J
      type
      Author
    6. name
      Hilsenbeck SG
      type
      Author
    7. name
      Rodriguez GI
      type
      Author
    8. name
      Thurman AM
      type
      Author
    9. name
      Smith LS
      type
      Author
    10. name
      Eckhardt SG
      type
      Author
    11. name
      Weiss GR
      type
      Author
    12. name
      Elfring GL
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Rothenberg ML
      type
      Author
    2. name
      Eckardt JR
      type
      Author
    3. name
      Kuhn JG
      type
      Author
    4. name
      Burris HA 3rd
      type
      Author
    5. name
      Nelson J
      type
      Author
    6. name
      Hilsenbeck SG
      type
      Author
    7. name
      Rodriguez GI
      type
      Author
    8. name
      Thurman AM
      type
      Author
    9. name
      Smith LS
      type
      Author
    10. name
      Eckhardt SG
      type
      Author
    11. name
      Weiss GR
      type
      Author
    12. name
      Elfring GL
      type
      Author
    bibliography ids
    1. nci-bib-e90a7a1d6f0a0e59e4395606
    book metadata
    content sha256
    93ebba9528648e792ee3ae493c4b571bb889f43779351da256ff58826fcefa63
    document type
    citation
    dois
    1. 10.1200/JCO.1996.14.4.1128
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:8648367
    immutable id
    pubmed:8648367@93ebba9528648e792ee3ae493c4b571bb889f43779351da256ff58826fcefa63
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    4
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1128-35
    volume
    14
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      8648367
      provenance
      batch id
      2752791f8cc3526b9192
      provider
      NCBI PubMed ESummary
      record sha256
      3117652d9b3657b3e087217ad2933effd75a9fddffb30eac9b35496da0a7ac70
      response sha256
      8db42d042a938e99e944b9e6af6caf1dd877725c05485e70efac12add1ee08e9
      retrieved at
      2026-09-09T23:45:25.088603+00:00
      publication date
      display
      1996 Apr
      precision
      month
      year
      1996
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/8648367/
      title
      Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

      Preserved source evidence · Independent clinical review pending · Not medical advice